Skip to main content
. 2020 May 7;12(5):1179. doi: 10.3390/cancers12051179

Table 2.

Selected inhibitors of Rho GTPase signaling.

Drug Name Target Protein Mechanism Refs
Rhosin RhoA Inhibit GEF biding [129]
Y16 LARG Inhibit RhoA binding [130]
NSC23766 Rac1 Inhibit GEF binding [132]
EHop-016 Rac1 Derivative of NSC23766 [133]
CASIN Cdc42 Inhibit GEF binding [134,135]
ZCL278 Cdc42 Inhibit GEF binding [136,137]
Y-27632 ROCK Compete with ATP [140]
Wf-536 ROCK Derivative of Y-27632 [144]
Fasudil ROCK Compete with ATP [141]
RKI-1447 ROCK Compete with ATP [144]
AT13148 ROCK Compete with ATP [146]
K252 PAK Compete with ATP [151]
OSU-03012 PAK Compete with ATP [152]
PF-3758309 PAK Compete with ATP [153]
FRAX597 PAK Compete with ATP [147]
IPA-3 PAK Promote auto-inhibited conformation [148]